The Effect of Convalescent Plasma Therapy on Patients with 19-COVID

The Effect of Convalescent Plasma Therapy on the Outcomes of Patients with 19-COVID

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150808023559N21

Enrollment

Registered

2020-05-09

Start date

2020-05-12

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid 19. COVID-19

Interventions

Intervention 1: Intervention group: Patients in the intervention group, in addition to routine treatment, will receive convalescent Plasma extracted from improved patients from 19-COVID in the amount

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Definitive diagnosis of Covid19 based on PCR Blood oxygen saturation less than 90% No recovery within 48 hours of routine treatment

Exclusion criteria

Exclusion criteria: History of allergic reactions to blood products injection

Design outcomes

Primary

Measure	Time frame
Reduction in all causes mortality. Timepoint: At the time of discharge of patients. Method of measurement: Patient documents.	—

Secondary

Measure	Time frame
Reduction of hospital stay. Timepoint: At the time of discharge of patients. Method of measurement: Patient documents.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEffat Irani Jam

Ardabil University of Medical Sciences

dr.jam733@gmail.com+98 45 3325 1410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026